Table 2

Localization of intradermally or s.c.-administered In-111-labeled DCs

Times.c. injection site maximum activity (%)Intradermal injection site maximum activity (%)Inguinal LN a draining ID site maximum activity (%)Inguinal LN draining ID site injection site activity (%)
1 min10010056 ± 50.08
6 hr93 ± 389 ± 175 ± 40.19
24 hr82 ± 477 ± 295 ± 70.37
48 hr70 ± 465 ± 492 ± 30.41
  • a LN, lymph nodes; ID, intradermal.